Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

A new shot to prevent HIV now has the government’s approval. The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. Two studies show that a drug named ...

By C.J. Atkins Just in time for Pride month, President Donald Trump and Health Secretary Robert F. Kennedy, Jr., have ...

Men, women, gay, straight – it really just kinds of expands the opportunity for prevention’ Source: Twice-a-year shot to prevent HIV could stop transmission — if people can get it – Zimbabwe News Now ...

The U.S. has just approved a powerful new weapon in the fight against HIV: a twice-a-year prevention shot called Yeztugo. Made by Gilead Sciences, the injectable treatment slashes the risk […] The ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they ...

The U.S. Food and Drug Administration has approved a groundbreaking new HIV prevention drug that offers near-total protection with just two injections per year. Sold under the name Yeztugo, the shot ...